Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision label v3.5.4 was added and the previous v3.5.3 was removed. This reflects an internal platform update and does not alter any study data or visible content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change without changing the displayed study information.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check78 days agoChange DetectedFooter revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check107 days agoChange DetectedThe page shows an updated revision label: v3.4.2 replaces the previous v3.4.1.SummaryDifference0.1%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.